company background image
MDKA logo

Medika d.d ZGSE:MDKA Stock Report

Last Price

€5.70k

Market Cap

€165.0m

7D

0.9%

1Y

-17.4%

Updated

22 Dec, 2024

Data

Company Financials

MDKA Stock Overview

Engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia. More details

MDKA fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

Medika d.d. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medika d.d
Historical stock prices
Current Share Price€5,700.00
52 Week High€7,700.00
52 Week Low€5,550.00
Beta0.073
1 Month Change0.89%
3 Month Change-1.72%
1 Year Change-17.39%
3 Year Change49.89%
5 Year Change161.90%
Change since IPO433.24%

Recent News & Updates

Recent updates

Statutory Profit Doesn't Reflect How Good Medika d.d's (ZGSE:MDKA) Earnings Are

Jul 29
Statutory Profit Doesn't Reflect How Good Medika d.d's (ZGSE:MDKA) Earnings Are

Shareholder Returns

MDKAHR HealthcareHR Market
7D0.9%-2.7%1.7%
1Y-17.4%1.9%28.3%

Return vs Industry: MDKA underperformed the HR Healthcare industry which returned 1.9% over the past year.

Return vs Market: MDKA underperformed the HR Market which returned 28.3% over the past year.

Price Volatility

Is MDKA's price volatile compared to industry and market?
MDKA volatility
MDKA Average Weekly Movementn/a
Healthcare Industry Average Movement4.2%
Market Average Movement3.6%
10% most volatile stocks in HR Market5.9%
10% least volatile stocks in HR Market2.2%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine MDKA's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19221,018Jasminko Hercegwww.medika.hr

Medika d.d., together with its subsidiaries, engages in the wholesale and retail distribution of pharmaceutical products in the Republic of Croatia. The company primarily sells, stores, and distributes human and veterinary drugs, and equipment and dental supplies, as well as dietetic, cosmetic, hygienic, medicinal, and other products. It serves pharmacies, healthcare institutions, hospitals, health centers, outpatient facilities, doctor’s offices, wholesalers, and specialized stores; and dental practices, veterinary clinics, and medical centers, as well as herbal pharmacies, companies, optics, and others.

Medika d.d. Fundamentals Summary

How do Medika d.d's earnings and revenue compare to its market cap?
MDKA fundamental statistics
Market cap€165.04m
Earnings (TTM)€20.23m
Revenue (TTM)€811.07m

8.2x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDKA income statement (TTM)
Revenue€811.07m
Cost of Revenue€746.12m
Gross Profit€64.96m
Other Expenses€44.72m
Earnings€20.23m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)698.83
Gross Margin8.01%
Net Profit Margin2.49%
Debt/Equity Ratio47.2%

How did MDKA perform over the long term?

See historical performance and comparison

Dividends

3.5%

Current Dividend Yield

29%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 04:41
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medika d.d. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution